Evidence map›Paper›PMID 36423011›Full record

ArticleVaccines2022

Effectiveness of the Booster of SARS-CoV-2 Vaccine among Japanese Adolescents: A Cohort Study.

Yoshika Saito, Kana Yamamoto, Morihito Takita, Masahiro Kami, Masaharu Tsubokura, Kenji Shibuya

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yoshika SaitoResearch Division, Medical Governance Research Institute, 2-12-13-201 Takanawa, Tokyo 108-0074, Japan.
Kana YamamotoResearch Division, Medical Governance Research Institute, 2-12-13-201 Takanawa, Tokyo 108-0074, Japan.
Morihito TakitaResearch Division, Medical Governance Research Institute, 2-12-13-201 Takanawa, Tokyo 108-0074, Japan.ORCID 0000-0003-2855-4155
Masahiro KamiResearch Division, Medical Governance Research Institute, 2-12-13-201 Takanawa, Tokyo 108-0074, Japan.
Masaharu TsubokuraDepartment of Radiation Health Management, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1247, Japan.ORCID 0000-0001-8027-202X
Kenji ShibuyaSoma COVID Vaccination Medical Center, 63-3 Nakamura-Kitamachi, Soma 976-8601, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccination is effective in preventing COVID-19-related hospitalization among all age groups, but there is limited evidence on the effectiveness of the booster of the SARS-CoV-2 vaccine among adolescents. We analyzed the data on the status of SARS-CoV-2 infection and their vaccination profiles in adolescents aged 13-18 years in Soma city (Fukushima, Japan) (

Indexed as

adolescentboosterCOVID-19infectionvaccination

Identifiers

PMID36423011
PMCPMC9693574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.